Chlormethiazole hydrochloride, >=98% (HPLC), powder

Chlormethiazole hydrochloride, >=98% (HPLC), powder

Biochem/physiol Actions

GABAA agonist; glycine receptor modulator.

Chlormethiazole serves as an anticonvulsant. It is useful in treating alcohol addiction and eclampsia. Chlormethiazole is also useful in treating convulsive status epilepticus. Long term administration of chlormethiazole leads to addiction to the drug.

Features and Benefits

This compound was developed by AstraZeneca. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

This compound is a featured product for ADME Tox and Neuroscience research. Discover more featured ADME Tox and Neuroscience products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

Packaging

10, 50 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level InChI key InChI Manufacturer Further Info Form Assay Price Quantity
3573302 Chlormethiazole hydrochloride, >=98% (HPLC), powder off-white 100 OFXYKSLKNMTBHK-UHFFFAOYSA-N 1S/C6H8ClNS.ClH/c1-5-6(2-3-7)9-4-8-5;/h4H,2-3H2,1H3;1H
£174.11 (exc VAT) per 10MG
-
+
3573303 Chlormethiazole hydrochloride, >=98% (HPLC), powder off-white 100 OFXYKSLKNMTBHK-UHFFFAOYSA-N 1S/C6H8ClNS.ClH/c1-5-6(2-3-7)9-4-8-5;/h4H,2-3H2,1H3;1H
£589.18 (exc VAT) per 50MG
-
+